After three years of the federal government picking up the bill for Covid-19 vaccines, tests and treatments, the Biden administration is about to shift the burden of paying to Americans.
According to the Wall Street Journal, the Department of Health and Human Services will hold a meeting later this month to make it easier for insurers and patients to pay for Covid-19 vaccines.
Stakeholders from across the healthcare industry will take part in the planning meeting, during which representatives from pharmacy chains, state health departments and drug producers are expected to begin laying out how insurance coverage and reimbursement would work with the shift
According to the Wall Street Journal, the biggest challenge to tackle will be how to make sure 30 million Americans with no healthcare coverage will be able to get vaccines and treatments.
As soon as this fall, the Biden administration could stop buying vaccines, treatments and tests, according to a White House official.
The Kaiser Family Foundation's Larry Levitt told the Wall Street Journal that a shift from the current model could mean billions of dollars in additional profit for companies that produce vaccines and antiviral treatments.
$7 billion. According to the Wall Street Journal, Pfizer and Moderna reported Covid-19 vaccine and treatments in their February earnings reports.
"I want to make sure that when we make this transition, we don't end up at a point where nobody can get a vaccine because we didn't get the transition right."
The national stockpile of Covid-19 tests and personal protective equipment were used last spring because of a stalemate in Congress over funding for the Pandemic response. The funds will be used to purchase updated booster shots that will protect against the new coronaviruses. Eli Lilly said it would shift to commercial sales after the Biden administration stopped funding supplies of its treatments.
Biden administration plans for end of covid-19 shot.
The Biden administration will stop buying Covid-19 in the fall.